Published Date: Feb-19
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Implantable Cardiac Monitors Market, published by KBV research, the LAMEA Implantable Cardiac Monitors Market would witness market growth of 8.5% CAGR during the forecast period (2018 – 2024).
The Brazil market would dominate the LAMEA Cardiac Arrhythmias Market by Country by 2024, growing at a CAGR of 7 % during the forecast period. The Argentina market is expected to witness a CAGR of 8.6% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 7.4% during (2018 - 2024).
The Hospitals market dominated the UAE Implantable Cardiac Monitors Market by End User 2017, and would achieve a market value of $6.9 million by 2024, growing at a CAGR of 7.4 % during the forecast period. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 8.4% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH, Schiller AG, Jarvik Heart, Inc.
LAMEA Implantable Cardiac Monitors Market Segmentation
By End User
Unique Offerings from KBV Research